PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1148
https://www.valueinhealthjournal.com/article/S1098-3015(12)01213-2/fulltext
Title :
PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01213-2&doi=10.1016/j.jval.2012.03.1148
First page :
A212
Section Title :
Cancer
Open access? :
No
Section Order :
668